Drug
Omadacycline clinical trials
Also written Nuzyra and PTK 0796.
- studies test it
- 21
- open now
- 3
- in phase 3
- 7
- first study started
- 2007
Keep track of what changes. Save the omadacycline studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 6
- Phase 3
- 7
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 7
Paratek Pharmaceuticals Inc (12) · Zai Lab (Hong Kong), Ltd. (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Paul Beringer (1) · University of Houston (1) · Wake Forest University Health Sciences (1) · Hartford Hospital (1) · Vancouver Coastal Health (1)
Often tested with
Tested in the same studies.
Amikacin (1) · Clofazimine (1) · Bedaquiline (1) · Linezolid (1) · Sulfamethoxazole (1) · Trimethoprim (1) · Imipenem (1) · Cilastatin (1)
Studies
Open first, then newest update. How each study uses omadacycline is read from its arms, and is right about nine times in ten.
Testing it · 21
- Omadacycline for Treatment Refractory Mycoplasma Genitalium UrethritisNot yet recruitingPhase 2Montefiore Medical CenterNCT07853742Written as Omadacycline Oral Tablet
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationPhase 1Vancouver Coastal HealthNCT07228702Written as Omadacycline Oral Tablet
- A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPRecruitingPhase 3Zai Lab (Hong Kong), Ltd.NCT06162286Written as Omadacycline
- Pharmacokinetics of Omadacycline in Cystic FibrosisCompletedPhase 4Paul BeringerNCT04460586Written as Omadacycline Injection [Nuzyra]
- Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial InfectionsCompletedPhase 1Paratek Pharmaceuticals IncNCT05217537Written as Omadacycline Injection [Nuzyra]
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint InfectionActive, not recruitingPhase 2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT05753215Written as Omadacycline Pill
- Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)CompletedPhase 2Paratek Pharmaceuticals IncNCT04922554Written as Omadacycline Oral Tablet
- Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial PneumoniaCompletedPhase 3Paratek Pharmaceuticals IncNCT04779242Written as Omadacycline
- Microbiome Effect of Omadacycline on Healthy VolunteersCompletedPhase 1University of HoustonNCT06030219Written as Omadacycline
- Effects of Intravenous (IV) Omadacycline on Gut MicrobiomeCompletedPhase 4Wake Forest University Health SciencesNCT05515562Written as Omadacycline Injection
- A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult VolunteersCompletedPhase 1Zai Lab (Hong Kong), Ltd.NCT06462326Written as Omadacycline Oral Tablet
- Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial PneumoniaCompletedPhase 1Paratek Pharmaceuticals IncNCT04160260Written as Omadacycline
- Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisCompletedPhase 1Hartford HospitalNCT04144374Written as Omadacycline
- Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)TerminatedPhase 3Paratek Pharmaceuticals IncNCT00865280Written as PTK 0796
- Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)CompletedPhase 2Paratek Pharmaceuticals IncNCT03716024Written as PTK 0796
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute PyelonephritisCompletedPhase 2Paratek Pharmaceuticals IncNCT03757234Written as Omadacycline
- Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of CystitisCompletedPhase 2Paratek Pharmaceuticals IncNCT03425396Written as Omadacycline tablets
- Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)CompletedPhase 3Paratek Pharmaceuticals IncNCT02378480Written as Omadacycline
- Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)CompletedPhase 3Paratek Pharmaceuticals IncNCT02531438Written as Omadacycline
- Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSICompletedPhase 3Paratek Pharmaceuticals IncNCT02877927Written as Omadacycline
Codes
What other systems call omadacycline · ClinicalTrials.gg INT000071
- MeSH (NLM) C000591640omadacyclineOne source NLM
- UNII (FDA) 090IP5RV8FOMADACYCLINEConfirmed FDA, NLM
- RxNorm 2059269One source FDA
- NCI Thesaurus C90688OmadacyclineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000591640 | omadacycline | One source NLM |
| UNII (FDA) | 090IP5RV8F | OMADACYCLINE | Confirmed FDA, NLM |
| RxNorm | 2059269 | — | One source FDA |
| NCI Thesaurus | C90688 | Omadacycline | One source FDA |
Also registered as omadacycline tosylate (UNII 5658Y89YCD · RxNorm 2059268).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.